About Omega Biotek
Omega Biotek is a Healthcare company based in Norcross (United States) founded in 1998. It offers DNA and RNA purification kits and automated systems for scientific applications. It operates on a B2B model. Its Indian entity Omega Biotech Limited reported revenue of ₹19.07 Cr. Omega Biotek offers products and services including Mag-Bind Blood & Tissue DNA Kit, Mag-Bind cfDNA Kit, and Mag-Bind Viral DNA/RNA Xpress Kit. Its focus areas include Biotechnology, Genomics, DNA/RNA Purification and Agriculture. Its competitors include ArcherDX, GenScript and OriGene; 3 of its 3 listed competitors have raised funding.
Company details
Omega Bio-tek develops and supplies innovative kits and automated solutions for DNA and RNA purification. Based in Norcross, Georgia, they cater to applications in genomics, oncology, agriculture, and biobanking. The company focuses on reliable extraction products and partners with clients like Myriad Genetics for customized needs, ensuring high-quality results in research and diagnostics.
- Headquarters Norcross, United States
- SectorsHealthcare
- Email••••••••
- Website omegabiotek.com
- Social LinkedIn X Facebook Instagram YouTube
- Legal Name Omega Bio-Tek, Inc.
- Date of Incorporation 08 Jul, 1994
- Indian entity revenue₹19.07 Cr
FY 2024 · +10% YoY
- Indian entity net profit₹12.3 Lakh
FY 2024 · 1% margin
- Indian entity EBITDA₹1.18 Cr
FY 2024 · 6% margin
Associated legal entities of Omega Biotek
Omega Biotek operates through Omega Biotech Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Omega Biotech Limited CIN U74899DL1994PLC060105 | Active | 08 Jul 1994 | New Delhi, Delhi | ₹19.1 Cr | 57 | 3 | View details |
Products & Services of Omega Biotek
Omega Biotek offers a comprehensive portfolio of products and services, including Mag-Bind Blood & Tissue DNA Kit, Mag-Bind cfDNA Kit, and Mag-Bind Viral DNA/RNA Xpress Kit.
Kit for isolating DNA from blood and tissue samples.
Kit for extracting cell-free DNA from preserved samples.
Kit for rapid purification of viral DNA and RNA.
Apps and channels of Omega Biotek
its YouTube channel Omega Bio-tek has 211 subscribers and 16 videos.
Videos from Omega Biotek
The most watched videos on Omega Biotek's YouTube channel, Omega Bio-tek (211 subscribers). Click a video to play it here.
More on Omega Bio-tek.
Board of directors of Omega Biotech Limited (Omega Biotek)
Omega Biotech Limited is the primary company behind Omega Biotek. The board of Omega Biotech Limited currently have 3 directors; the longest-serving is Hariom Parkash Aggarwal, appointed in 2002. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Hariom Parkash Aggarwal DIN 00224685 | Director | 25 Jun 2002 | 24 yrs 4 mo | Omega Biotech Limited |
| Girish Chand Sharma DIN 05261848 | Director | 03 Oct 2011 | 15 yrs | Omega Biotech Limited |
| Bipul Shankar Singh DIN 05261830 | Director | 01 Apr 2024 | 2 yrs 6 mo | Omega Biotech Limited |
Financials of Omega Biotek
Figures of Omega Biotech Limited, the primary company behind Omega Biotek, for FY 2024. Revenue was ₹19.07 Cr (+10% year on year). Net profit was ₹12.3 Lakh (1% margin). EBITDA was ₹1.18 Cr (6% margin). Revenue has grown at a compounded annual rate of -16% over three years and -20% over five years.
- ₹19.07 CrRevenue · FY 2024 · +10% YoY
- ₹12.3 LakhNet profit · 1% margin
- ₹1.18 CrEBITDA · 6% margin
- ₹3.05 CrPaid-up capital
- 57Employees (provident fund records)
- -16%Revenue CAGR, 3 years
- -20%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Omega Biotech Limited are on its company page.
Detailed financial statements for Omega Biotek
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Omega Biotek
Omega Biotek has 3 listed competitors in our database, 3 of them funded. They include ArcherDX, GenScript and OriGene.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| archerdx.com | 2013 | Boulder, United States | $152.6M | 429 | Molecular cancer diagnostic products are developed using patented AMP technology. | |
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. |
Detailed competitors of Omega Biotek
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Omega Biotek
Websites that share an audience with Omega Biotek (omegabiotek.com).
Websites whose visitors overlap most with Omega Biotek. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ozbiosciences.com | 92% | 18.7K | #1,484,401 | View details | |
| dianova.com | 89% | 6.5K | #3,245,925 | View details | |
| twistbioscience.com | 73% | 167.6K | #226,348 | View details | |
| qiagen.com | 53% | 458.2K | #105,023 | View details |
Top companies in Clinical Genomics
3 companies that operate in the same segment as Omega Biotek (Clinical Genomics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Omega Biotek
Complete news archive for Omega Biotek
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Omega Biotek
Omega Biotek was founded in 1998.
Omega Biotek is headquartered in Norcross, United States. It is registered at Norcross, Georgia, United States.
The primary company behind Omega Biotek, Omega Biotech Limited, reported revenue of ₹19.07 Cr for FY 2024, up 10% year on year.
Omega Bio-tek develops and supplies innovative kits and automated solutions for DNA and RNA purification. Based in Norcross, Georgia, they cater to applications in genomics, oncology, agriculture, and biobanking. The company focuses on reliable extraction products and partners with clients like Myriad Genetics for customized needs, ensuring high-quality results in research and diagnostics.
Omega Biotek offers Mag-Bind Blood & Tissue DNA Kit, Mag-Bind cfDNA Kit, and Mag-Bind Viral DNA/RNA Xpress Kit.
Omega Biotek operates through Omega Biotech Limited.
The legal entities of Omega Biotek currently have 3 directors, including Hariom Parkash Aggarwal, Girish Chand Sharma, Bipul Shankar Singh.